Arterra Bioscience S.p.A. (BIT: ARBS)
Health Care · Biotechnology · IT
€3.06
+0.33% today · +19.5% 1Y
Arterra Bioscience S.p.A. (BIT: ARBS) operates in the Biotechnology industry within the Health Care sector. The company is valued at $23.79M and employs 36 people.
Over the last twelve months the share price has gained 19.5%, trading between 2.46 and 3.58.
Tweenvest scores Arterra Bioscience S.p.A. across four factors: quality 72/100, value 35/100, growth 83/100, dividend 90/100. Its strongest factor is dividend.
ARBS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $23.79M
- Revenue (TTM)
- $5.52M
- P/E
- 10.16
- EPS
- 0.30
- Dividend yield
- 4.26%
- Beta (5Y)
- 0.64
- 52-week high
- €3.58
- 52-week low
- €2.46
- Avg volume (3M)
- —
- Shares outstanding
- 6.66M
- Employees
- 36
- Next earnings
- —
About Arterra Bioscience S.p.A.
Arterra Bioscience S.p.A. is a biotechnology company fundamentally driven by scientific research, concentrating on the discovery and development of a wide range of ingredients and nature-based solutions. The firm's activities encompass the creation of advanced technological frameworks, innovative extraction methodologies, and foundational raw materials, specifically tailored for the beauty, agricultural, and nutritional supplement sectors. Established in 2003, Arterra Bioscience S.p.A. is headquartered in Naples, Italy.
- Founded
- 2003
- Listed since
- Oct 28, 2019
- Exchange
- Borsa Italiana
- Currency
- EUR
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.96 | +1.20% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $439.33 | +1.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.12 | +1.86% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €902.00 | +1.90% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $145.13 | +0.04% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.